Neurociencias
Fachbereich
Guillermo
Izquierdo Ayuso
Publikationen, an denen er mitarbeitet Guillermo Izquierdo Ayuso (42)
2024
-
Early beginning of alemtuzumab: changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study
Neurologia, Vol. 39, Núm. 5, pp. 383-391
2022
-
Consensus on early detection of disease progression in patients with multiple sclerosis
Frontiers in Neurology, Vol. 13
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
2020
-
XII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2019 (I)
Revista de neurologia, Vol. 70, Núm. 10, pp. 379-390
-
XII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2019 (II)
Revista de neurologia, Vol. 70, Núm. 11, pp. 417-429
2019
-
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease
PLoS Genetics, Vol. 15, Núm. 6
-
Recomendaciones de uso de cladribina comprimidos en la esclerosis múltiple recurrente
Revista de neurologia, Vol. 69, Núm. s02, pp. 1-9
-
Review of the novelties presented at the 2018 ECTRIMS congress: 11th post-ECTRIMS meeting (II)
Revista de Neurologia, Vol. 68, Núm. 11, pp. 468-479
-
Review of the novelties presented at the 2018 ectrims congress: 11th post-ectrims meeting (I)
Revista de Neurologia, Vol. 68, Núm. 10, pp. 431-441
-
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
The Lancet Neurology, Vol. 18, Núm. 9, pp. 845-856
2018
-
Review of the novelties from the 2017 ECTRIMS congress, presented at the 10th post-ectrims meeting (I)
Revista de Neurologia, Vol. 67, Núm. 1, pp. 15-27
-
Review of the novelties from the 2017 ectrims congress, presented at the 10th post-ectrims meeting (II)
Revista de Neurologia, Vol. 67, Núm. 2, pp. 50-62
2017
-
Revisión de las novedades del XXXII Congreso ECTRIMS 2016, presentadas en la IX Reunión Post-ECTRIMS (II)
Revista de Neurologia, Vol. 65, Núm. 2, pp. 75-84
-
Revisión de las novedades del XXXII congreso ectrims 2016, presentadas en la ix reunión post-ectrims (I)
Revista de Neurologia, Vol. 65, Núm. 1, pp. 31-40
2016
-
Analysis of plasminogen genetic variants in multiple sclerosis patients
G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079
-
Revisión de las novedades del XXXI Congreso ECTRIMS 2015, presentadas en la VIII Reunión Post-ECTRIMS
Revista de Neurologia, Vol. 62, Núm. 12, pp. 559-569
2015
-
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis
Human Molecular Genetics, Vol. 24, Núm. 19, pp. 5619-5627
-
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice
Clinica Chimica Acta, Vol. 438, pp. 67-69
-
Consenso español actualizado sobre el uso del natalizumab (Tysabri®)-2013
Neurologia, Vol. 30, Núm. 5, pp. 302-314
-
Genome-wide significant association with seven novel multiple sclerosis risk loci
Journal of Medical Genetics, Vol. 52, Núm. 12, pp. 848-855